biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Johnny boy

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jun 30, 2023 8:47am

256 Views

Post# 35521913

RE:RE:RE:RE:Johnny boy

I am sure it is fun for you since this message board is all you have in your life.

Staying until the Bioasis story is resolved? Ummm, it's been resolved. It's actually been resolved for years. You were just too ingorant to see what the end was going to be. Game over

Enjoy being broke knowing you wasted years and years of your life on a pennystock scam.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale